PRIME GENOMICS, INC. — Form D/A
PRIME GENOMICS, INC. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2014-01-14. The offering totals $800K, of which $325K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-01-14
- Form: D/A
- Accession: 0001537877-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $325K
- Remaining: $475K
- Minimum investment: $3K
- Investors: 8
- Date of first sale: 2012-11-27
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-187919
Issuer
- Name: PRIME GENOMICS, INC.
- CIK: 0001537877
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2011
- Address: 111 COMMONWEALTH, SAN FRANCISCO, CA, 94118
- Phone: 415-572-8126
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Robert R Tufts | Director | San Francisco, CA |
| Robert R Tufts | Promoter | San Francisco, CA |
| ALAN R BRIMM | Promoter | SAN FRANCISCO, CA |
| PETER V GROETZINGER | Promoter | SAN FRANCISCO, CA |
| THOMAS W LOKER | Executive Officer | SAN FRANCISCO, CA |
| SANDY C SHAW | Director | SAN FRANCISCO, CA |
| SANDY C SHAW | Executive Officer | SAN FRANCISCO, CA |
| SANDY C SHAW | Promoter | SAN FRANCISCO, CA |
| SCOTT R GREENSTONE | Director | MILL VALLEY, CA |
Other filings by this issuer (3)
More